Interaction of bacteria with antigen presenting cells: Influences on antigen presentation and antibacterial immunity

Current Opinion in Immunology

Volumn 15, Issue 1, 2003, Pages 112-119

  Harding, Clifford V ^a   Ramachandra, Lakshmi ^a   Wick, Mary Jo ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; BACTERIAL ANTIGEN; HISTOCOMPATIBILITY ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BACTERIAL IMMUNITY; BACTERIUM; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNE RESPONSE; MACROPHAGE; MOLECULAR INTERACTION; NONHUMAN; REVIEW; T LYMPHOCYTE; ANIMAL; BACTERIAL INFECTION; HUMAN; IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; BACTERIA; BACTERIAL INFECTIONS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNITY, CELLULAR;

EID: 0037290896     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00008-0     Document Type: Review

References (75)

1. Svensson M., Johansson C., Wick M.J. Salmonella enterica serovar Typhimurium-induced maturation of bone marrow-derived dendritic cells. Infect. Immun. 68:2000;6311-6320.
2. Svensson M., Johannson C., Wick M.J. Salmonella typhimurium-induced cytokine production and surface molecule expression by murine macrophages. Microb. Pathog. 31:2001;91-102.
3. Austyn JM: Mobilization, migration and localization of dendritic cells. In Dendritic cells, edn 2. Edited by Lotze MT, Thomson AW. San Diego, USA: Academic Press; 2001:131-149.
4. Steinman R.M., Whitmer M.D. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U.S.A. 75:1978;5132-5136.
5. Gagnon E., Duclos S., Rondeau C., Chevet E., Cameron P.H., Steele-Mortimer O., Paiement J., Bergeron J.J., Desjardins M. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell. 110:2002;119-131 This paper introduces a novel model wherein the ER interacts directly with phagosomes.
6. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359-362.
7. Wick M.J., Ljunggren H.-G. Processing of bacterial antigens for peptide presentation on MHC class I molecules. Immunol. Rev. 172:1999;153-162.
8. Jayawardena-Wolf J., Bendelac A. CD1 and lipid antigens: intracellular pathways for antigen presentation. Curr. Opin. Immunol. 13:2001;109-113.
9. Barton G.M., Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:2002;380-383.
10. Ramachandra L., Noss E., Boom H.W., Harding C.V. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility class II complexes and is inhibited by live bacilli that decrease phagosome maturation. J. Exp. Med. 194:2001;1421-1432.
11. Ramachandra L., Song R., Harding C.V. Phagosomes are fully competent antigen processing organelles that mediate the formation of peptide:class II MHC complexes. J. Immunol. 162:1999;3263-3272.
12. Ramachandra L., Harding C.V. Phagosomes acquire nascent and recycling class II MHC molecules but primarily use nascent molecules in phagocytic antigen processing. J. Immunol. 164:2000;5103-5112.
13. Via L.E., Deretic D., Ulmer R.J., Hibler N.S., Huber L.A., Deretic V. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. J. Biol. Chem. 272:1997;13326-13331.
14. Hmama Z., Gabathuler R., Jefferies W.A., de Jong G., Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161:1998;4882-4893.
15. Ferrari G., Naito M., Langen H., Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell. 97:1999;435-447.
16. Ullrich H.-J., Beatty W.L., Russell D.G. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J. Immunol. 165:2000;6073-6080.
17. Wojciechowski W., DeSanctis J., Skamene E., Radzioch D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis Bacillus Calmette-Geurin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 163:1999;2688-2696.
18. Noss E.H., Pai R.K., Sellati T.J., Radolf J.D., Belisle J., Golenbock D.T., Boom W.H., Harding C.V. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J. Immunol. 167:2001;910-918 This paper describes the ability of M. tuberculosis to inhibit MΦ antigen processing via a TLR2-dependent pathway. The specific inhibitor was biochemically characterized, isolated and identified as a 19 kDa lipoprotein. This inhibitory mechanism may allow M. tuberculosis bacilli to immunologically silence the MΦs in which they reside, promoting evasion of T cell responses.
19. Zhong G., Fan T., Liu L. Chlamydia inhibits interferon γ-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189:1999;1931-1937.
20. Clemens D.L., Horwitz M.A. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. J. Exp. Med. 181:1995;257-270.
21. Clemens D.L., Lee B.Y., Horwitz M.A. Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate. Infect. Immun. 68:2000;2671-2684.
22. Sturgill-Koszycki S., Schlesinger P.H., Chakraborty P., Haddix P.L., Collins H.L., Fok A.K., Allen R.D., Gluck S.L., Heuser J., Russell D.G. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science. 263:1994;678-681.
23. Alpuche-Aranda C.M., Swanson J.A., Loomis W.P., Miller S.I. Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10079-10083.
24. Alpuche-Aranda C.M., Racoosin E.L., Swanson J.A., Miller S.I. Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes. J. Exp. Med. 179:1994;601-608.
25. Alpuche-Aranda C.M., Berthiaume E.P., Mock B., Swanson J.A., Miller S.I. Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect. Immun. 63:1995;4456-4462.
26. Wick M.J., Harding C.V., Twesten N.J., Normark S.J., Pfeifer J.D. The phoP locus influences processing and presentation of S. typhimurium antigens by activated macrophages. Mol. Microbiol. 16:1995;465-476.
27. Niedergang F., Sirard J.-C., Tallichet Blanc C., Kraehenbuhl J.-P. Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors. Proc. Natl. Acad. Sci. U.S.A. 97:2000;14650-14655.
28. De Lerma Barbaro A., Tosi G., Frumento G., Bruschi E., D'Agostino A., Valle M.T., Manca F., Accolla R.S. Block of Stat-1 activation in macrophages phagocytosing bacteria causes reduced transcription of CIITA and consequent impaired antigen presentation. Eur. J. Immunol. 32:2002;1309-1318.
29. Noss E.H., Harding C.V., Boom W.H. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201:2000;63-74.
30. De Lerma Barbaro A., Tosi G., Valle M.T., Megiovanni A.M., Sartoris S., D'Agostino A., Soro O., Mingari M.C., Canonica G.W., Manca F.et al. Distinct regulation of HLA class II and class I cell surface expression in the THP-1 macrophage cell line after bacterial phagocytosis. Eur. J. Immunol. 29:1999;499-511.
31. Dalpke A.H., Opper S., Zimmermann S., Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166:2001;7082-7089.
32. Ting L.-M., Kim A.C., Cattamanchi A., Ernst J.D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163:1999;3898-3906.
33. Zhong G., Fan P., Dong H.J.F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:2001;935-942 This work together with [19,39] elegantly characterize the ability of the obligate intracellular pathogen Chlamydia to modulate IFN-γ-inducible MHC-I and MHC-II expression. In this study, Zhong and co-workers clone and purify a Chlamydia proteasome-like activity factor (CPAF) that is secreted into the host cytosol and modulates MHC expression by degrading the host transcription factors RFX5 and UAF-1.
34. Matousek M.P., Nedrud J.G., Harding C.V. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J. Immunol. 156:1996;4137-4145.
35. Matousek M.P., Nedrud J.N., Cieplak W., Harding C.V. Inhibition of class II MHC antigen processing and presentation by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Infect. Immun. 66:1998;3480-3484.
36. Millar D.G., Hirst T.R. Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments. Cell. Microbiol. 3:2001;311-329.
37. Gagliardi M.C., Sallusto F., Marinaro M., Langenkamp A., Lanzavecchia A., De Magistris M.T. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur. J. Immunol. 30:2000;2394-2403.
38. Ågren L.C., Ekman L., Löwenadler L., Lycke N.Y. Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. J. Immunol. 158:1997;3936-3946.
39. Zhong G., Liu L., Fan T., Fan P., Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon γ-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J. Exp. Med. 191:2000;1525-2534.
40. Huang F., Yamaguchi A., Tsuchiya N., Ikawa T., Tamura N., Virtala M.M., Granfors K., Yasaei P., Yu D.T. Induction of alternative splicing of HLA-B27 by bacterial invasion. Arthritis Rheum. 40:1997;694-703.
41. Kirveskari J., He Q., Leirisalo-Repo M., Maki-Ikola O., Wuorela M., Putto-Laurila A., Granfors K. Enterobacterial infection modulates major histocompatibility complex class I expression on mononuclear cells. Immunology. 97:1999;420-428.
42. Wuorela M., Jalkanen S., Kirveskari J., Laitio P., Granfors K. Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes. Infect. Immun. 65:1997;2060-2066.
43. Maksymowych W.P., Ikawa T., Yamaguchi A., Ikeda M., McDonald D., Laouar L., Lahesmaa R.T.N., Khuong A., Yu D.T., Kane K.P. Invasion by Salmonella typhimurium induces increased expression of the LMP, MECL, and PA28 proteasome genes and changes in the peptide repertoire of HLA-B27. Infect. Immun. 66:1998;4624-4632.
44. vanHeyningen T.K., Collins H.L., Russell D.G. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J. Immunol. 158:1997;330-337.
45. Reiling N., Blumenthal A., Flad H.-D., Ernst M., Ehlers S. Mycobacteria-induced TNF-α and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167:2001;3339-3345.
46. Giancomini E., Iona E., Ferroni L., Miettinen M., Fattorini L., Orefici G., Julkunen I., Coccia E.M. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166:2001;7033-7041.
47. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J.J. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculosis granulamotous lung lesions. J. Immunol. 154:1995;465-473.
48. Sing A., Roggenkamp A., Geiger A.M., Hessemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168:2002;1315-1321.
49. McGuirk P., McCann C., Mills K.H.G. Pathogen-specific regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195:2002;221-231 McGuirk and colleagues demonstrate that B. pertussis filamentous hemagglutinin (FHA) induces DCs to produce IL-10. Moreover, they show that the IL-10-producing DCs generated by exposure to FHA direct naïve T cells into IL-10-producing regulatory T cells that suppress protective (IFN-γ producing) Th1 responses against B. pertussis. Thus, B. pertussis exploits the host's capacity to produce IL-10 as a means to modulate the immune response.
50. Schesser K., Spiik A.-K., Dukuzumuremyi J.-M., Neurath M.F., Pettersson P., Wolf-Watz H. The yopJ locus is required for Yersinia-mediated inhibition of NF-κB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28:1998;1067-1079.
51. Yao T., Mecsas J., Healy J.I., Falkow S., Chien Y.-H. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, YopH. J. Exp. Med. 190:1999;1343-1350.
52. + T cells.
53. Henderson R.A., Watkins S.C., Flynn J.L. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159:1997;635-643.
54. Rescigno M., Citterio S., Thèry C., Rittig M., Medaglini D., Pozzi G., Amigorena S., Ricciardi-Castagnoli P. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5229-5234.
55. Askew D., Chu R.S., Krieg A.M., Harding C.V. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen processing mechanisms. J. Immunol. 165:2000;6889-6895.
56. + dendritic cells. J. Immunol. 166:2001;5000-5007.
57. •,59,60], is an elegant study that describes changes that occur in the biology of DCs involved in regulating presentation of antigens as they undergo maturation.
58. •].
59. Pierre P., Turley S.J., Gatti E., Hull M., Meltzer J., Mirza A., Inaba K., Steinman R.M., Mellman I. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature. 388:1997;787-792.
60. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:1997;782-787.
61. Yrlid U., Svensson M., Johansson C., Wick M.J. Salmonella infection of bone marrow-derived macrophage and dendritic cells: influence on antigen presentation and initiating an immune response. FEMS Immunol. Med. Microbiol. 27:2000;313-320.
62. Chu R.S., Askew D., Noss E.H., Tobian A., Krieg A.M., Harding C.V. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 163:1999;1188-1194.
63. Hartmann G., Weiner G.J., Krieg A.M. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9305-9310.
64. Jakob T., Walker P.S., Krieg A.M., Udey M.C., Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161:1998;3042-3049.
65. Kirby A.C., Yrlid U., Svensson M., Wick M.J. Differential involvement of dendritic cell subsets during acute Salmonella infection. J. Immunol. 166:2001;6802-6811.
66. Jiao X., Lo-Man R., Guermonprez P., Fiette L., Dériaud D., Burgaud S., Gicquel B., Winter N., Leclerc C. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:2002;1294-1301.
67. Kirby A.C., Yrlid U., Wick M.J. The innate immune response differs in primary and Salmonella infection. J. Immunol. 169:2002;4450-4459.
68. Yrlid U., Svensson M., Chambers B., Ljunggren H.-G., Wick M.J. In vivo activation of dendritic cells and T cells during Salmonella enterica serovar Typhimurium infection. Infect. Immun. 69:2001;5726-5735.
69. Hamerman J.A., Aderem A. Functional transitions in macrophages during in vivo infection with Mycobacterium bovis Bacillus Calmette-Guérin. J. Immunol. 167:2001;2227-2233.
70. Salcedo S.P., Noursadeghi M., Cohen J., Holden D.W. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell. Microbiol. 3:2001;587-597.
71. Skoberne M., Schenk S., Hof H., Geginat G. Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes. J. Immunol. 169:2002;1410-1418.
72. Yrlid U., Wick M.J. Antigen presentation capacity and cytokine production by murine splenic dendritic cell subsets upon Salmonella encounter. J. Immunol. 169:2002;108-116.
73. + T lymphocytes by Salmonella typhimurium is independent of Salmonella pathogenicity island 1-mediated host cell death. J. Immunol. 169:2002;3275-3283.
74. + T cells to exogenous antigens, including the facultative intracellular bacterium L. monocytogenes.
75. Yrlid U., Wick M.J. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191:2000;613-623.